Philips Zenition 90 Motorized Mobile C-Arm Receives FDA Clearance

June 17, 2024—Royal Philips announced FDA 510(k) clearance and the launch of Zenition 90 Motorized, the company’s image-guided therapy mobile C-arm system 9000. The company stated that the new system with expanded capabilities is designed to meet complex vascular needs as well as a range of clinical procedures, such as cardiac interventions, pain management, and urology.

According to Philips, the system features intuitive motorization for greater control and high power (25 kW) for state-of-the-art image quality. Automated workflows contribute to greater flexibility and independence for clinicians, and the intuitive C-arm allows clinicians to control it from the table side. The touch-screen module and the software solutions facilitate user-friendly controls and time saving.

The company noted that many of these innovations in image capture and processing, ease of use, and versatility were pioneered on Philips’ Azurion platform. Additionally, Philips leveraged its EcoDesign process for the Zenition 90 Motorized to improve product life by 25% and power efficiency by 13%.

The system is also available in a nonmotorized configuration, stated the company.

Philips advised it will be showcasing the Zenition 90 Motorized mobile C-arm at VAM24, the Society for Vascular Surgery’s 2024 Vascular Annual Meeting held June 19-22 in Chicago, Illinois.